These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36179875)

  • 1. Multifunctional nanoparticles based on marine polysaccharides for apremilast delivery to inflammatory macrophages: Preparation, targeting ability, and uptake mechanism.
    Shabana S; Hamouda HI; Abdalla M; Sharaf M; Chi Z; Liu C
    Int J Biol Macromol; 2022 Dec; 222(Pt B):1709-1722. PubMed ID: 36179875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Enteromorpha prolifera polysaccharide-based nanoparticles for delivery of curcumin to cancer cells.
    Li J; Jiang F; Chi Z; Han D; Yu L; Liu C
    Int J Biol Macromol; 2018 Jun; 112():413-421. PubMed ID: 29410267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of polysaccharides from Ophiopogon japonicus (OJPs) using OJPs/chitosan/whey protein co-assembled nanoparticles to treat defective intestinal epithelial tight junction barrier.
    Lin C; Kuo TC; Lin JC; Ho YC; Mi FL
    Int J Biol Macromol; 2020 Oct; 160():558-570. PubMed ID: 32464213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages-targeting mannosylated nanoparticles based on inulin for the treatment of inflammatory bowel disease (IBD).
    Sun Q; Arif M; Chi Z; Li G; Liu CG
    Int J Biol Macromol; 2021 Feb; 169():206-215. PubMed ID: 33340633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
    Wang F; Yang Y; Ju X; Udenigwe CC; He R
    J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
    Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia.
    Liu L; Yao W; Xie X; Gao J; Lu X
    J Nanobiotechnology; 2021 Aug; 19(1):235. PubMed ID: 34362394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
    Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
    Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Du Z; Liu J; Zhang H; Wu X; Zhang B; Chen Y; Liu B; Ding L; Xiao H; Zhang T
    J Agric Food Chem; 2019 Nov; 67(45):12511-12519. PubMed ID: 31626537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.
    Coco R; Plapied L; Pourcelle V; Jérôme C; Brayden DJ; Schneider YJ; Préat V
    Int J Pharm; 2013 Jan; 440(1):3-12. PubMed ID: 22820482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier.
    Wu SJ; Don TM; Lin CW; Mi FL
    Mar Drugs; 2014 Nov; 12(11):5677-97. PubMed ID: 25421323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
    Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
    J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermosensitive hydrogel with emodin-loaded triple-targeted nanoparticles for a rectal drug delivery system in the treatment of chronic non-bacterial prostatitis.
    Ye Y; Zhong W; Luo R; Wen H; Ma Z; Qi S; Han X; Nie W; Chang D; Xu R; Ye N; Gao F; Zhang P
    J Nanobiotechnology; 2024 Jan; 22(1):33. PubMed ID: 38238760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
    Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B
    Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Characterization of Mucoadhesive Nanoparticles for Enhancing Cellular Uptake of Coenzyme Q10.
    Lee JS; Suh JW; Kim ES; Lee HG
    J Agric Food Chem; 2017 Oct; 65(40):8930-8937. PubMed ID: 28933847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium Dodecyl Sulfate-Modified Doxorubicin-Loaded Chitosan-Lipid Nanocarrier with Multi Polysaccharide-Lecithin Nanoarchitecture for Augmented Bioavailability and Stability of Oral Administration In Vitro and In Vivo.
    Su CW; Chiang MY; Lin YL; Tsai NM; Chen YP; Li WM; Hsu CH; Chen SY
    J Biomed Nanotechnol; 2016 May; 12(5):962-72. PubMed ID: 27305818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.